Advanced search×

Leveling the field in the treatment of rheumatoid arthritis with biologic therapies: equal access for equal efficacy.

Clin Rheumatol 29(3):233-9 (2010) PMID 20039183

DOI: 10.1007/s10067-009-1338-1
Version: za2963e q8za5 q8zb5 q8zc7 q8zd4 q8ze2 q8zf6 q8zg8

Similar articles you may find interesting…

  1. mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids.

    Endocr Relat Cancer (2013) PMID 23653462

    We search for possible markers of mTOR inhibitors efficacy, that may help in identifying the patients that may benefit from mTOR inhibitors treatment, sparing them from ineffective therapy. We found that NVP-BEZ235 is twice as potent as Everolimus in reducing cell viability and activating apoptosis...
  2. Sub-acute administration of (S)-dimethyl 2-(3-(phenyltellanyl) propanamido) succinate induces toxicity and oxidative stress in mice: unexpec...

    SpringerPlus 2(1):182 (2013) PMID 23658858

    The organic tellurium compound (S)-dimethyl 2-(3-(phenyltellanyl) propanamide) succinate (TeAsp) exhibits thiol-peroxidase activity that could potentially offer protection against oxidative stress. However, data from the literature show that tellurium is a toxic agent to rodents. In...
  3. Uridine Prodrug Improves Memory in Tg2576 and TAPP Mice and Reduces Pathological Factors associated with Alzheimer's Disease in Related Mode...

    J Alzheimers Dis (2013) PMID 23648515

    Uridine prodrug PN401 has been shown to have neuroprotective effects in models of Parkinson's disease and Huntington's disease. These age-related neurodegenerative diseases including Alzheimer's disease (AD) are associated with mitochondrial dysfunction, oxidative stress, and inflamm...